Renton William D, Carmody Jake, Mactaggart Emma, Akikusa Jonathan D
Rheumatology Service, Department of General Medicine, The Royal Children's Hospital, Melbourne, Australia.
School of Clinical Sciences at Monash Health, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, Australia.
J Paediatr Child Health. 2025 Aug;61(8):1301-1305. doi: 10.1111/jpc.70115. Epub 2025 Jun 14.
Anecdotally, in some centres in Australia and New Zealand, there is difficulty in obtaining early echocardiograms in patients with Kawasaki disease (KD) considered at low risk of coronary artery (CA) involvement, justified by the argument that the risk of coronary artery aneurysm (CAA) is low and that results will not change management. We sought to determine how often in practice the results of early echocardiography alter management in patients with KD, particularly in those at low risk of medium-giant aneurysms.
A retrospective chart review of patients with KD at a large paediatric tertiary referral centre was performed. Data collected included demographic features, echocardiography results, and treatments. Analysis of data was stratified by risk of coronary involvement using criteria prospectively defined by the study authors.
Of the 147 included patients, 53 (36.1%) were female and the mean age was 3.4 years (range 0.3-11.4 years). 13 (8.8%) had aneurysms on baseline echocardiogram; 4/86 'low-risk' (4.7%) and 9/61 (14.7%) 'high-risk' patients (odds ratio 3.55; 95% confidence interval 1.04-12.11). Baseline echocardiogram findings changed management in three 'low-risk' patients who had primary treatment intensification. Seven 'high-risk' patients had changes in management including primary treatment intensification, additional anti-platelet treatment, and anticoagulation.
These data support recommendations for baseline echocardiography in all patients with KD regardless of perceived risk of CAA. Further research into risk stratification in KD is required.
据传闻,在澳大利亚和新西兰的一些中心,对于被认为冠状动脉(CA)受累风险较低的川崎病(KD)患者,早期获取超声心动图存在困难,理由是冠状动脉瘤(CAA)风险低且结果不会改变治疗方案。我们试图确定在实际中早期超声心动图结果改变KD患者治疗方案的频率,尤其是在那些中大型动脉瘤低风险患者中。
对一家大型儿科三级转诊中心的KD患者进行回顾性病历审查。收集的数据包括人口统计学特征、超声心动图结果和治疗情况。使用研究作者前瞻性定义的标准,根据冠状动脉受累风险对数据进行分层分析。
在纳入的147例患者中,53例(36.1%)为女性,平均年龄为3.4岁(范围0.3 - 11.4岁)。13例(8.8%)在基线超声心动图检查时有动脉瘤;4/86例“低风险”患者(4.7%)和9/61例(14.7%)“高风险”患者(优势比3.55;95%置信区间1.04 - 12.11)。基线超声心动图检查结果改变了3例接受强化初始治疗的“低风险”患者的治疗方案。7例“高风险”患者的治疗方案发生了改变,包括强化初始治疗、额外的抗血小板治疗和抗凝治疗。
这些数据支持对所有KD患者进行基线超声心动图检查的建议,无论其CAA风险如何。需要对KD的风险分层进行进一步研究。